Literature DB >> 11371407

Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.

J M Marin1, S J Carrizo, M Gascon, A Sanchez, B Gallego, B R Celli.   

Abstract

Patients with severe chronic obstructive pulmonary disease (COPD) develop dynamic lung hyperinflation (DH) during symptom-limited incremental and constant work exercise with cycle ergometer and treadmill. The increase in end-expiratory lung volume seems to be the best predictor of dyspnea. Quantification of DH is based on the relatively complex use of on-line measurement of inspiratory capacity (IC) from flow volume loops. We reasoned that DH could occur during daily activities such as walking, and that it could be simply measured using the spirometrically determined IC. We studied 72 men with COPD (FEV(1) = 45 +/- 13.3% predicted). IC was measured at rest and after a 6-min walk test. Exertional dyspnea was evaluated using the Borg scale and dyspnea during daily activities with the modified Medical Research Council (MRC) scale. IC decreased significantly from 28.9 +/- 6.7% TLC at rest to 24.1 +/- 6.8% TLC after exercise (p < 0.001). Exertional dyspnea correlated with DeltaIC (r = -0.49, p < 0.00001) and baseline MRC (r = 0.59, p < 0.00001). In many patients with COPD, walking leads to DH that can be easily determined with simple spirometric testing. DH helps explain exercise capacity limitation and breathlessness during simple daily activities.

Entities:  

Mesh:

Year:  2001        PMID: 11371407     DOI: 10.1164/ajrccm.163.6.2003172

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  69 in total

1.  Quantifying bronchodilator responses in chronic obstructive pulmonary disease trials.

Authors:  Federico Lavorini
Journal:  Br J Clin Pharmacol       Date:  2005-04       Impact factor: 4.335

2.  Effect of Yoga Breathing (Pranayama) on Exercise Tolerance in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Controlled Trial.

Authors:  David A Kaminsky; Kalpalatha K Guntupalli; Joan Lippmann; Stephanie M Burns; Melissa A Brock; Joan Skelly; Michael DeSarno; Heidi Pecott-Grimm; Ali Mohsin; Catherine LaRock-McMahon; Penney Warren; Martha C Whitney; Nicola A Hanania
Journal:  J Altern Complement Med       Date:  2017-07-17       Impact factor: 2.579

Review 3.  Guideline-oriented perioperative management of patients with bronchial asthma and chronic obstructive pulmonary disease.

Authors:  Michiaki Yamakage; Sohshi Iwasaki; Akiyoshi Namiki
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

4.  Extrinsic Threshold PEEP Reduces Post-exercise Dyspnea in COPD Patients: A Placebo-controlled, Double-blind Cross-over Study.

Authors:  A Daniel Martin; Paul W Davenport
Journal:  Cardiopulm Phys Ther J       Date:  2011-09

5.  Predictors of dynamic hyperinflation during the 6-minute walk test in stable chronic obstructive pulmonary disease patients.

Authors:  Rui Chen; Lin Lin; Jing-Wei Tian; Bin Zeng; Lei Zhang; Xin Chen; Hai-Yan Yan
Journal:  J Thorac Dis       Date:  2015-07       Impact factor: 2.895

6.  [Main parameters of lung function in chronic obstructive pulmonary disease (COPD)].

Authors:  J M Marín Trigo
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

Review 7.  The role of a multidisciplinary severe chronic obstructive pulmonary disease hyperinflation service in patient selection for lung volume reduction.

Authors:  Joyce Chew; Ravi Mahadeva
Journal:  J Thorac Dis       Date:  2018-10       Impact factor: 2.895

8.  The six minute walk test accurately estimates mean peak oxygen uptake.

Authors:  Robert M Ross; Jayasimha N Murthy; Istvan D Wollak; Andrew S Jackson
Journal:  BMC Pulm Med       Date:  2010-05-26       Impact factor: 3.317

Review 9.  Impact of bronchodilator therapy on exercise tolerance in COPD.

Authors:  B Aguilaniu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

10.  Study of the burden on patients with chronic obstructive pulmonary disease.

Authors:  J L Izquierdo; C Barcina; J Jiménez; M Muñoz; M Leal
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.